Fortress Biotech to Participate in December 2019 Investor Conferences

    NEXT STORY
    FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems for Multiple eClinical Products
    PREV STORY
    Intercept Pharmaceuticals Appoints Jason Campagna as Chief Medical Officer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Celularity Receives Orphan Drug Designation for Natural Killer Cell Therapy CYNK-001 in the Treatment of Malignant Gliomas

    author_avatar
    NASDAQ Market News

    Point-of-Care (POC) Diagnostics Devices & Equipment Markets, 2015-2019 & 2020-2030

    author_avatar
    NASDAQ Market News

    VBL Therapeutics to Present at the Oppenheimer 27th Annual Healthcare Conference

    TEL AVIV, Israel, March 15, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

    author_avatar
    NASDAQ Market News